Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers

ClinicalTrials.gov ID: NCT02780414

Public ClinicalTrials.gov record NCT02780414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Preeclampsia (Pre-E) is a hypertensive disease of pregnancy with multi-system involvement that usually occurs in the second half of pregnancy. Pre-E occurs in 5% to 7% of U.S. pregnancies, and is the third-leading cause of U.S. maternal death. Improvements to the current diagnostic paradigm have been evaluated. However, no stand-alone diagnostic method has emerged that more accurately identifies women at risk for preeclampsia, warranting improvements in diagnosing Pre-E. This sample collection study will obtain serum and urine samples from pregnant women who present with clinical signs, symptoms, or conditions contributing to the suspicion of Pre-E. Samples will be used to evaluate and validate the performance of an assay intended to aid in assessing the risk of Pre-E.

Study identification

NCT ID
NCT02780414
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Progenity, Inc.
Industry
Enrollment
1,730 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2016 (Actual)
Primary completion
Sep 29, 2020 (Actual)
Completion
Oct 23, 2020 (Actual)
Last update posted
Mar 11, 2022

2016 – 2020

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
Center of Research in Women's Health Birmingham Alabama 35294 —
University of Colorado Aurora Colorado 80045 —
Yale Medical New Haven Connecticut 06520 —
Northwestern Chicago Illinois 60611 —
Indiana University Health Physicians Women's Health Indianapolis Indiana 46202 —
Johns Hopkins Medicine Baltimore Maryland 21287 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Washington Univ School of Medicine - Dept of OB-GYN St Louis Missouri 63111 —
Winthrop Clinical Trials Center Mineola New York 11501 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7516 —
Duke University Durham North Carolina 27705 —
Good Samaritan Hospital Cincinnati Ohio 45220 —
University of Oklahoma Oklahoma City Oklahoma 73104 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Regional Obstetrical Consultants, PC Chattanooga Tennessee 37403 —
Austin Maternal Fetal Medicine Austin Texas 78758 —
University of Texas Medical Branch, Galveston Galveston Texas 77555 —
UT Health Medical School Houston Texas 77030 —
University of Utah Hospital, OB/GYN Dept. Salt Lake City Utah 84132 —
Medical College of Wisconsin - Department of Obstetrics & Gynecology Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02780414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02780414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →